BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND TNFAIP3, TNFA1P2, 7128, ENSG00000118503, OTUD7C, MGC138687, MGC104522, A20, MGC138688, P21580
32 results:

  • 1. Prognostic Model for High-Grade Neuroendocrine Carcinoma of the Lung Incorporating Genomic Profiling and Poly (ADP-ribose) Polymerase-1 Expression.
    Kim HS; Kim JK; Lee JH; Lee YJ; Lee GK; Han JY
    JCO Precis Oncol; 2024 Apr; 8():e2300495. PubMed ID: 38635931
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Complexity of Being a20: From Biological Functions to Genetic Associations.
    Karri U; Harasimowicz M; Carpio Tumba M; Schwartz DM
    J Clin Immunol; 2024 Mar; 44(3):76. PubMed ID: 38451381
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. TNIP2 inhibits amyloidogenesis by regulating the 3'UTR of BACE1: An in vitro study.
    Chen L; Wang L; Zhou GF; Liu Y; Chen X; Xie XY; Wen QX; Li CL; Yang J; Chen GJ
    Neurosci Lett; 2023 Jun; 808():137265. PubMed ID: 37085111
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. AN1-type zinc finger protein 3 (ZFAND3) is a transcriptional regulator that drives Glioblastoma invasion.
    Schuster A; Klein E; Neirinckx V; Knudsen AM; Fabian C; Hau AC; Dieterle M; Oudin A; Nazarov PV; Golebiewska A; Muller A; Perez-Hernandez D; Rodius S; Dittmar G; Bjerkvig R; Herold-Mende C; Klink B; Kristensen BW; Niclou SP
    Nat Commun; 2020 Dec; 11(1):6366. PubMed ID: 33311477
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. a20 regulates the therapeutic effect of anti-PD-1 immunotherapy in melanoma.
    Guo W; Ma J; Guo S; Wang H; Wang S; Shi Q; Liu L; Zhao T; Yang F; Chen S; Chen J; Zhao J; Yu C; Yi X; Yang Y; Ma J; Ni Q; Zhu G; Gao T; Li C
    J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33298620
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. a20 promotes melanoma progression via the activation of Akt pathway.
    Ma J; Wang H; Guo S; Yi X; Zhao T; Liu Y; Shi Q; Gao T; Li C; Guo W
    Cell Death Dis; 2020 Sep; 11(9):794. PubMed ID: 32968045
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. TNIP1-mediated TNF-α/NF-κB signalling cascade sustains glioma cell proliferation.
    Lei Q; Gu H; Li L; Wu T; Xie W; Li M; Zhao N
    J Cell Mol Med; 2020 Jan; 24(1):530-538. PubMed ID: 31691497
    [TBL] [Abstract] [Full Text] [Related]  

  • 8.
    Nanbakhsh A; Srinivasamani A; Holzhauer S; Riese MJ; Zheng Y; Wang D; Burns R; Reimer MH; Rao S; Lemke A; Tsaih SW; Flister MJ; Lao S; Dahl R; Thakar MS; Malarkannan S
    Cancer Immunol Res; 2019 Oct; 7(10):1647-1662. PubMed ID: 31515257
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Improving outcome of valve replacement for carcinoid heart disease.
    Nguyen A; Schaff HV; Abel MD; Luis SA; Lahr BD; Halfdanarson TR; Connolly HM
    J Thorac Cardiovasc Surg; 2019 Jul; 158(1):99-107.e2. PubMed ID: 30527716
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Nedd4-Binding Protein 1 and tnfaip3-Interacting Protein 1 Control MHC-1 Display in Neuroblastoma.
    Spel L; Nieuwenhuis J; Haarsma R; Stickel E; Bleijerveld OB; Altelaar M; Boelens JJ; Brummelkamp TR; Nierkens S; Boes M
    Cancer Res; 2018 Dec; 78(23):6621-6631. PubMed ID: 30213788
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. CD4
    Haabeth OAW; Fauskanger M; Manzke M; Lundin KU; Corthay A; Bogen B; Tveita AA
    Cancer Res; 2018 Aug; 78(16):4573-4585. PubMed ID: 29752262
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Local Delivery of OncoVEX
    Moesta AK; Cooke K; Piasecki J; Mitchell P; Rottman JB; Fitzgerald K; Zhan J; Yang B; Le T; Belmontes B; Ikotun OF; Merriam K; Glaus C; Ganley K; Cordover DH; Boden AM; Ponce R; Beers C; Beltran PJ
    Clin Cancer Res; 2017 Oct; 23(20):6190-6202. PubMed ID: 28706012
    [No Abstract]    [Full Text] [Related]  

  • 13. Development of new PTK7-targeting aptamer-fluorescent and -radiolabelled probes for evaluation as molecular imaging agents: Lymphoma and melanoma in vivo proof of concept.
    Calzada V; Moreno M; Newton J; González J; Fernández M; Gambini JP; Ibarra M; Chabalgoity A; Deutscher S; Quinn T; Cabral P; Cerecetto H
    Bioorg Med Chem; 2017 Feb; 25(3):1163-1171. PubMed ID: 28089349
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Inhibition of a20 expression in tumor microenvironment exerts anti-tumor effect through inducing myeloid-derived suppressor cells apoptosis.
    Shao B; Wei X; Luo M; Yu J; Tong A; Ma X; Ye T; Deng H; Sang Y; Liang X; Ma Y; Wu Q; Du W; Du J; Gao X; Wen Y; Fu P; Shi H; Luo S; Wei Y
    Sci Rep; 2015 Nov; 5():16437. PubMed ID: 26561336
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. germline variation of tnfaip3 in primary Sjögren's syndrome-associated lymphoma.
    Nocturne G; Tarn J; Boudaoud S; Locke J; Miceli-Richard C; Hachulla E; Dubost JJ; Bowman S; Gottenberg JE; Criswell LA; Lessard CJ; Sivils KL; Carapito R; Bahram S; Seror R; Ng WF; Mariette X
    Ann Rheum Dis; 2016 Apr; 75(4):780-3. PubMed ID: 26338037
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. An A/C germline single-nucleotide polymorphism in the tnfaip3 gene is associated with advanced disease stage and survival in only surgically treated esophageal cancer.
    Ghadban T; Schmidt-Yang M; Uzunoglu FG; Perez DR; Tsui TY; El Gammal AT; Erbes PJ; Zilbermints V; Wellner U; Pantel K; Izbicki JR; Vashist YK
    J Hum Genet; 2014 Dec; 59(12):661-6. PubMed ID: 25354935
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The tumor necrosis factor alpha-induced protein 3 (tnfaip3, a20) imposes a brake on antitumor activity of CD8 T cells.
    Giordano M; Roncagalli R; Bourdely P; Chasson L; Buferne M; Yamasaki S; Beyaert R; van Loo G; Auphan-Anezin N; Schmitt-Verhulst AM; Verdeil G
    Proc Natl Acad Sci U S A; 2014 Jul; 111(30):11115-20. PubMed ID: 25024217
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Differential effects of antofine N-oxide on solid tumor and leukemia cells.
    Bour T; Yang X; Li W; Bernardin F; Kaoma T; Muller A; Vallar L; Steinmetz A
    Anticancer Agents Med Chem; 2014; 14(10):1315-23. PubMed ID: 24962072
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. miR-125b controls apoptosis and temozolomide resistance by targeting tnfaip3 and NKIRAS2 in glioblastomas.
    Haemmig S; Baumgartner U; Glück A; Zbinden S; Tschan MP; Kappeler A; Mariani L; Vajtai I; Vassella E
    Cell Death Dis; 2014 Jun; 5(6):e1279. PubMed ID: 24901050
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A vaccine that co-targets tumor cells and cancer associated fibroblasts results in enhanced antitumor activity by inducing antigen spreading.
    Gottschalk S; Yu F; Ji M; Kakarla S; Song XT
    PLoS One; 2013; 8(12):e82658. PubMed ID: 24349329
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.